Fedratinib
ATC L01EJ02 · 8 markets · 10 records
AU 3 records · 3 strengths
- 100 mgcapsuleInrebic
- 117.3 mgcapsuleINREBIC fedratinib (as hydrochloride) 100 mg capsule bottle
Records without a stated strength · 1 Inrebic
US 1 records · 1 strengths
- 100 mgcapsuleInrebic
GB 1 records · 1 strengths
- 100 mgcapsuleInrebic
CA 1 records · 1 strengths
- 100 mgcapsuleInrebic
SG 1 records · 1 strengths
- 100 mgcapsuleInrebic
ES 1 records · 1 strengths
- 100 mgcapsuleInrebic
TW 1 records · 1 strengths
Records without a stated strength · 1 Inrebic、恩瑞比膠囊
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Inrebic
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | EU |
|---|---|---|---|---|---|---|---|---|
| 100 mg capsule | Inrebic | Inrebic | Inrebic | Inrebic | Inrebic | Inrebic | ||
| 117.3 mg capsule | INREBIC fedratinib (as hydrochloride) 100 mg capsule bottle | |||||||
capsule | Inrebic 恩瑞比膠囊 | |||||||
unknown | Inrebic | Inrebic |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.